Haryana has no report on Coronil efficacy: RTI thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Sputnik V is one of the three vaccines currently approved by DCGI for use in India. (Representative image).
CHANDIGARH: An international pharmaceutical company with its headquarters in Malta -Pharma Regulatory Services Limited has given an expression of Interest to Haryana Medical Services Corporation Limited (HMSCL) to provide up to 60 million doses of Sputnik V vaccine manufactured by Gamaleya Institute and Russian Direct Investment Fund (RDIF).
Sputnik V is one of the three vaccines currently approved by DCGI for use in India. As per the offer made by the firm, per dose cost of the vaccine would be around Rs 1120. The firm has further given a timeline of 30 days to supply the first batch of 500000 followed by 1 million doses every 20 days till supply is completed against a letter of credit issued in their name.